Chance, Change, or Shock? A Stochastic Landscape Theory of Escape from Cancer Dormancy and Its Signatures in Relapse-Time Data

Many cancers recur years after apparently curative treatment, because residual tumour cells persist in a dormant, immune-controlled state before resuming growth. Why and when dormancy ends remains a fundamental open question. We formulate this question mathematically and show that it can be answered from data.We model the residual tumour burden as a one-dimensional Itô diffusion with logistic proliferation, saturating (Hill-type) immune killing and environmental multiplicative noise. In dimensionless form the model has two parameters and a closed-form bistability region bounded by a cusp, in which a dormant state and a progressive state coexist. We prove that the process is well posed and positive, give the stationary density in closed form, derive the exact mean relapse time and its Eyring–Kramers asymptotics, and validate all of them against Fokker–Planck and Monte Carlo computations.We then distinguish three mechanisms of dormancy escape: chance (noise-driven crossing of a fixed barrier), change (slow erosion of the barrier, e.g. immune decline) and shock (a transient perturbation, e.g. surgery-induced inflammation). We show that these mechanisms leave distinct, testable signatures. Chance yields an asymptotically constant hazard of relapse. Change yields a strictly increasing hazard, a coefficient of variation below one and rising variance and autocorrelation in serial biomarkers. Shock yields a transient hazard spike followed by a return to baseline.Because any mixture of constant hazards has a non-increasing hazard, an increasing cohort-level relapse hazard falsifies pure chance-driven escape, whatever the heterogeneity between patients. These results turn the question “chance or change?” into hypotheses that existing relapse data and serial biomarker data can test.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24303202
Primary Topic
Mathematical Biology Tumor Growth
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Chance, Change, or Shock? A Stochastic Landscape Theory of Escape from Cancer Dormancy and Its Signatures in Relapse-Time Data

Kiran Kalyankar, Sakshi Sharma
4 links
Zenodo (CERN European Organization for Nuclear Research)
Mathematical Biology Tumor Growth
preprint

Chance, Change, or Shock? A Stochastic Landscape Theory of Escape from Cancer Dormancy and Its Signatures in Relapse-Time Data

Kiran Kalyankar, Sakshi Sharma
preprint en

Abstract

Many cancers recur years after apparently curative treatment, because residual tumour cells persist in a dormant, immune-controlled state before resuming growth. Why and when dormancy ends remains a fundamental open question. We formulate this question mathematically and show that it can be answered from data.We model the residual tumour burden as a one-dimensional Itô diffusion with logistic proliferation, saturating (Hill-type) immune killing and environmental multiplicative noise. In dimensionless form the model has two parameters and a closed-form bistability region bounded by a cusp, in which a dormant state and a progressive state coexist. We prove that the process is well posed and positive, give the stationary density in closed form, derive the exact mean relapse time and its Eyring–Kramers asymptotics, and validate all of them against Fokker–Planck and Monte Carlo computations.We then distinguish three mechanisms of dormancy escape: chance (noise-driven crossing of a fixed barrier), change (slow erosion of the barrier, e.g. immune decline) and shock (a transient perturbation, e.g. surgery-induced inflammation). We show that these mechanisms leave distinct, testable signatures. Chance yields an asymptotically constant hazard of relapse. Change yields a strictly increasing hazard, a coefficient of variation below one and rising variance and autocorrelation in serial biomarkers. Shock yields a transient hazard spike followed by a return to baseline.Because any mixture of constant hazards has a non-increasing hazard, an increasing cohort-level relapse hazard falsifies pure chance-driven escape, whatever the heterogeneity between patients. These results turn the question “chance or change?” into hypotheses that existing relapse data and serial biomarker data can test.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Mathematical Biology Tumor Growth
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon